Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemostasis in liver diseases].

M Udvardy1, E Pósán, I Tornai

  • 1Debreceni Orvos- és Egészségtudományi Egyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika.

Orvosi Hetilap
|June 10, 2000
PubMed
Summary

Liver failure causes bleeding and clotting issues, complicating treatment. Managing complications like esophageal varices and thrombosis in liver disease requires careful consideration of coagulation factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation.

Transplantation proceedings·2016
Same author

Gender, aging and power in sub-Saharan Africa: Challenges and puzzles.

Journal of cross-cultural gerontology·2014
Same author

The fertility of the post-fertile: Concepts of gender, aging and reproductive health among the Giriama of Kenya.

Journal of cross-cultural gerontology·2014
Same author

Erratum.

Journal of cross-cultural gerontology·2014
Same author

Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.

International journal of immunopathology and pharmacology·2011
Same author

Possible role for platelet insulin receptors in modulating platelet function in health and diabetes mellitus.

Platelets·2010

Area of Science:

  • Hematology
  • Hepatology
  • Vascular Biology

Context:

  • The liver is crucial for synthesizing blood coagulation factors.
  • Liver failure leads to complex hemostatic disturbances, including bleeding and thrombosis.
  • Managing patients with liver disease involves addressing both bleeding risks and thromboembolic events.

Purpose:

  • To review the multifaceted hemostatic challenges in liver disease.
  • To discuss the clinical implications of coagulation abnormalities in liver failure.
  • To highlight current therapeutic strategies and unresolved issues in managing bleeding and clotting disorders associated with liver conditions.

Summary:

  • Liver failure significantly impacts blood coagulation, leading to diverse bleeding manifestations like thrombocytopenia and esophageal varices.
  • Despite thrombocytopenia, bleeding is often less severe than other clotting abnormalities.
  • Transjugular intrahepatic shunt (TIPS) improves outcomes for esophageal bleeding and ascites but stent patency remains a challenge.
  • Venous thromboembolic events are not uncommon in cirrhosis, complicating patient management.
  • Ascites and conditions like Budd-Chiari syndrome present unique coagulation-related problems, especially during medical and interventional therapy.

Impact:

  • Improved understanding of the complex interplay between liver function and hemostasis.
  • Informed clinical decision-making for managing bleeding and thrombotic complications in liver disease.
  • Highlights the need for further research into optimizing treatments for liver disease-related hemostatic disorders and TIPS management.

Related Experiment Videos